Alejandro Raimondi

628 total citations
23 papers, 419 citations indexed

About

Alejandro Raimondi is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Alejandro Raimondi has authored 23 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 6 papers in Physiology and 5 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Alejandro Raimondi's work include Respiratory Support and Mechanisms (9 papers), Asthma and respiratory diseases (6 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). Alejandro Raimondi is often cited by papers focused on Respiratory Support and Mechanisms (9 papers), Asthma and respiratory diseases (6 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). Alejandro Raimondi collaborates with scholars based in Argentina, United Kingdom and Spain. Alejandro Raimondi's co-authors include Katina M. Wilson, Lorie Leo, Jorge Di Paola, Steven R. Lentz, Shawn M. Jobe, Jeffery D. Molkentin, Aquiles J. Roncoroni, Davide Lombardi, Néstor A. Molfino and Norman L. Jones and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and CHEST Journal.

In The Last Decade

Alejandro Raimondi

20 papers receiving 400 citations

Peers

Alejandro Raimondi
David C. Kressin United States
Cynthia Zamora United States
Rana Rustom United Kingdom
Fenny Berends Netherlands
George A. Fritsma United States
David C. Kressin United States
Alejandro Raimondi
Citations per year, relative to Alejandro Raimondi Alejandro Raimondi (= 1×) peers David C. Kressin

Countries citing papers authored by Alejandro Raimondi

Since Specialization
Citations

This map shows the geographic impact of Alejandro Raimondi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Raimondi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Raimondi more than expected).

Fields of papers citing papers by Alejandro Raimondi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandro Raimondi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Raimondi. The network helps show where Alejandro Raimondi may publish in the future.

Co-authorship network of co-authors of Alejandro Raimondi

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandro Raimondi. A scholar is included among the top collaborators of Alejandro Raimondi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandro Raimondi. Alejandro Raimondi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al‐Lehebi, Riyad, Mona Al‐Ahmad, Venkata Nagarjuna Maturu, et al.. (2024). Real-World Effectiveness of Mepolizumab in Severe Asthma: Results from the Multi-country, Self-controlled Nucala Effectiveness Study (NEST). Advances in Therapy. 41(11). 4008–4031. 6 indexed citations
2.
Raimondi, Alejandro, Vanessa M. McDonald, Ratko Djukanović, et al.. (2023). Patients' knowledge, perspectives and attitudes towards treatment goals and clinical remission in severe asthma. PA1895–PA1895.
3.
Torre‐Bouscoulet, Luis, et al.. (2021). Mepolizumab para el tratamiento de asma grave eosinofílica. SHILAP Revista de lepidopterología. 67.
4.
Rodríguez, Pablo, Norberto Tiribelli, Sebastián Fredes, et al.. (2020). Prevalence of Reverse Triggering in Early ARDS. CHEST Journal. 159(1). 186–195. 20 indexed citations
5.
Hernández, Paola, Mauricio Cabrera, Hugo Cerecetto, et al.. (2019). Identification and characterization of human interferon alpha inhibitors through a WISH cell line-based reporter gene assay. Bioorganic Chemistry. 94. 103372–103372. 4 indexed citations
6.
Rodríguez, Pablo, Norberto Tiribelli, Gustavo Plotnikow, et al.. (2019). Automatic detection of reverse-triggering related asynchronies during mechanical ventilation in ARDS patients using flow and pressure signals. Journal of Clinical Monitoring and Computing. 34(6). 1239–1246. 17 indexed citations
7.
Luna, Carlos M., et al.. (2014). The role of surveillance cultures in guiding ventilator-associated pneumonia therapy. Current Opinion in Infectious Diseases. 27(2). 184–193. 8 indexed citations
8.
Raimondi, Alejandro, Isabel Blanco, Xavier Pomares, & Joan Albert Barberà. (2013). Pulmonary Arterial Hypertension in a Patient With Hereditary Hemorrhagic Telangiectasia. Archivos de Bronconeumología. 49(3). 119–121. 6 indexed citations
9.
Raimondi, Alejandro, Isabel Blanco, Xavier Pomares, & Joan Albert Barberà. (2012). Hipertensión arterial pulmonar en un paciente con telangiectasia hemorrágica hereditaria. Archivos de Bronconeumología. 49(3). 119–121. 4 indexed citations
10.
Rodríguez, Pablo, et al.. (2010). Enfermedad respiratoria grave en terapia intensiva durante la pandemia por el virus de influenza A (H1N1) 2009. Medicina-buenos Aires. 70(5). 401–407. 2 indexed citations
11.
Jobe, Shawn M., Katina M. Wilson, Lorie Leo, et al.. (2007). Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis. Blood. 111(3). 1257–1265. 173 indexed citations
12.
Menga, Guillermo, et al.. (2005). CONSENSO ARGENTINO DE VENTILACION NO INVASIVA. Medicina-buenos Aires. 65(5). 437–457. 2 indexed citations
13.
Raimondi, Alejandro, et al.. (1997). Treatment of Acute Severe Asthma With Inhaled Albuterol Delivered via Jet Nebulizer, Metered Dose Inhaler With Spacer, or Dry Powder. CHEST Journal. 112(1). 24–28. 52 indexed citations
14.
Abbate, Eduardo, et al.. (1993). [Standards established by consensus for the treatment of bronchial asthma and its exacerbations].. PubMed. 53(3). 249–59. 4 indexed citations
15.
Raimondi, Alejandro, et al.. (1986). Comparison Between High and Moderate Doses of Hydrocortisone in the Treatment of Status Asthmaticus. CHEST Journal. 89(6). 832–835. 29 indexed citations
16.
Raimondi, Alejandro, et al.. (1986). Asthma, Cardiac Arrhythmias, and Albuterol Aerosol. CHEST Journal. 89(2). 192–194. 6 indexed citations
17.
Raimondi, Alejandro, Daniel G. Olmedo, & Aquiles J. Roncoroni. (1978). Acute miliary tuberculosis presenting as acute respiratory failure. Intensive Care Medicine. 4(4). 207–209. 10 indexed citations
18.
Simon, George R., N. B. Pride, Norman L. Jones, & Alejandro Raimondi. (1973). Relation between abnormalities in the chest radiograph and changes in pulmonary function in chronic bronchitis and emphysema. Thorax. 28(1). 15–23. 30 indexed citations
19.
Raimondi, Alejandro, G. R. Massarella, & N. B. Pride. (1971). The effects of ventilation on the elastic recoil of excised dogs' lungs. Respiration Physiology. 12(2). 205–217. 6 indexed citations
20.
Raimondi, Alejandro, et al.. (1969). Cardiovascular and renal adaptation to anoxia.. PubMed. 19(1). 49–55. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026